NP / PA
Camino-Benech Company, LLC
Camino-Benech Company, LLC was paid $775K by Medicaid between Oct 2021 and Dec 2024, across 49 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoCAMINO-BENECH COMPANY, LLC
HOUSTON, TX 77031
HOUSTON, TX 77031
33aNPI1194320598assigned 12/02/2020
33bProvider typeFamily Nurse Practitioner
28Total paid$775K
24GClaims32,221
24DCodes billed49
24AFirst – last monthOct 2021 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Texas
Rank by total paid#16 of 344
Median peer was paid$14K
This provider vs. median56×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 971 | $25K | |
| 2022 | 8,491 | $196K | |
| 2023 | 11,680 | $261K | |
| 2024incomplete | 11,079 | $293K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 6,759 | 4,715 | $236K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 4,243 | 3,369 | $208K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.7% | 743 | 731 | $59K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 7.6% | 309 | 69 | $59K |
| 99000 | 5.7% | 4,710 | 3,981 | $44K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.3% | 420 | 418 | $33K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.3% | 1,851 | 1,387 | $26K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.4% | 662 | 598 | $18K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.3% | 227 | 226 | $17K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 1.8% | 58 | 56 | $14K |
| 97802 | 1.7% | 1,168 | 1,124 | $13K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.4% | 818 | 754 | $11K |
37 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 142 | $11K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 655 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 319 | $5K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 82 | $4K |
| 99441 | <1% | 192 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 96 | $1K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 14 | $966.64 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 110 | $778.74 |
| 99442 | <1% | 17 | $480.57 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 27 | $389.19 |
| 90473 | <1% | 16 | $82.56 | |
| 81001 | <1% | 24 | $33.60 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 95 | $9.90 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 785 | $5.08 |
| 36415 | Collection of venous blood by venipuncture | 0% | 2,793 | $0.00 |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 0% | 834 | $0.00 |
| 90688 | 0% | 137 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 79 | $0.00 |
| 99172 | 0% | 109 | $0.00 | |
| 90686 | 0% | 32 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 246 | $0.00 |
| 96127 | 0% | 102 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 127 | $0.00 |
| 95024 | 0% | 59 | $0.00 | |
| 99402 | 0% | 19 | $0.00 | |
| 90651 | 0% | 24 | $0.00 | |
| 90696 | 0% | 12 | $0.00 | |
| 99401 | 0% | 1,261 | $0.00 | |
| 99071 | 0% | 818 | $0.00 | |
| 90633 | 0% | 84 | $0.00 | |
| 99173 | 0% | 784 | $0.00 | |
| 90715 | 0% | 12 | $0.00 | |
| 90710 | 0% | 14 | $0.00 | |
| 95144 | 0% | 48 | $0.00 | |
| 90670 | 0% | 52 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 14 | $0.00 |
| 90461 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBENECH-JIMENEZ, YAMIL (OWNER)